Kansas City, MONCT07524907Now EnrollingIRB Ready

Malnutrition (Calorie) Clinical Trial in Kansas City, MO

Access cutting-edge malnutrition (calorie) treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by Abbott Nutrition

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access malnutrition (calorie) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related malnutrition (calorie) treatment provided free

Apply for This Kansas City Location

Check if you qualify for this malnutrition (calorie) clinical trial in Kansas City, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Malnutrition (Calorie) Study in Kansas City

The objective of this prospective, real-world evidence/pragmatic study with a quality improvement program approach is to evaluate the feasibility and effectiveness of a community-engaged nutrition-focused program utilizing nutrition screening, education, supplementation and continuous follow up for children and their families.

Sponsor: Abbott Nutrition

Who Can Participate

Inclusion Criteria

Children aged 1-5 years experiencing stunting or its risk (defined as HAZ ≤ -1 SD at baseline)
Children's legal guardian agrees to participate in the study
Full term pregnancy (defined as ≥ 37 weeks gestation and ≥ 2500g birth weight)
Residence in study area attending Children International (NGO) centers

Exclusion Criteria

• Children who have current medical conditions requiring hospitalization: gastrointestinal tract infections or inflammatory bowel disease; active tuberculosis; acute hepatitis B or C; human immunodeficiency virus OR malignancy; cystic fibrosis; immunodeficiency syndromes, congenital abnormalities of the respiratory tract, such as lung and respiratory cilia; an unsuspected foreign body in the respiratory tract; asthma; heart abnormalities; abdominal hernias; and known metabolic disorders, renal impairment, or rheumatic diseases and diabetes
Congenital condition
Children with disabilities such as cerebral palsy, autism spectrum disorder, neurodegenerative disorders
Children with chronic or acute infections e.g. HIV, malaria
Children who are taking medications or other agents that could potentially affect body weight, including diuretics, appetite stimulants, steroids, and growth hormones
Children who have genetic conditions impacting weight status such as but not limited to: Bardet-Biedl Syndrome, Prader-Willi Syndrome
Children already enrolled in a nutrition program that includes a supplement
Participant has an allergy or intolerance to any ingredient in the study supplement, as reported by the parent.
Children with sleep disorders such as but not limited to: obstructive sleep apnea, insomnia, parasomnias (sleepwalking, night terrors, bedwetting), delayed sleep phase syndrome, behavioral sleep disorders, circadian rhythm disorders
Mental health disorders such as but not limited to: anxiety, depression Organization Component Inclusion
NGO staff taking part in nutrition screenings
Agrees to participate in survey Exclusion
Not involved in the implementation of the study
Not involved in working with pediatric stunting or its risk
Declines participation in survey

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT07524907) has an active research site in Kansas City, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Malnutrition (Calorie) Treatment Options in Kansas City, MO

If you're searching for malnutrition (calorie) treatment options in Kansas City, MO, this clinical trial (NCT07524907) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced malnutrition (calorie) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all malnutrition (calorie) clinical trials near you to find additional studies recruiting in your area.

More Lupus Nephritis Trials in Kansas City, MO

See all lupus nephritis clinical trials recruiting in Kansas City — not just this study.

Browse Lupus Nephritis Trials in Kansas City →

Browse More Trials by Condition

Lupus Nephritis TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, MO